StockData
Phathom Pharmaceuticals, Inc. logo

Phathom Pharmaceuticals, Inc. (PHAT) stock

PHATNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/30
$5.50−0.38 (-6.46%)

Close on Nov 17, 2026Market cap $447.10MP/E –Yield –

Phathom Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Phathom Pharmaceuticals's operating cash flow for the twelve months ending Sep 30, 2026 was -$20.74M. For fiscal 2025 it was -$166.78M. The highest annual figure on record is -$1.02M in fiscal 2018.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$166.78M–
FY2024Dec 31, 2024-$266.77M–
FY2023Dec 31, 2023-$137.58M–
FY2022Dec 31, 2022-$146.53M–
FY2021Dec 31, 2021-$148.46M–
FY2020Dec 31, 2020-$69.69M–
FY2019Dec 31, 2019-$36.51M–
FY2018Dec 31, 2018-$1.02M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.84M–
Q2 FY2026Jun 30, 2026-$1.93M–
Q1 FY2026Mar 31, 2026-$15.65M–
Q4 FY2025Dec 31, 2025-$5.00M–
Q3 FY2025Sep 30, 2025-$14.12M–
Q2 FY2025Jun 30, 2025-$62.73M–
Q1 FY2025Mar 31, 2025-$84.93M–
Q4 FY2024Dec 31, 2024-$63.46M–
Q3 FY2024Sep 30, 2024-$63.57M–
Q2 FY2024Jun 30, 2024-$70.72M–
Q1 FY2024Mar 31, 2024-$69.02M–
Q4 FY2023Dec 31, 2023-$43.80M–
Q3 FY2023Sep 30, 2023-$31.91M–
Q2 FY2023Jun 30, 2023-$22.20M–
Q1 FY2023Mar 31, 2023-$39.67M–
Q4 FY2022Dec 31, 2022-$41.04M–
Q3 FY2022Sep 30, 2022-$35.02M–
Q2 FY2022Jun 30, 2022-$25.72M–
Q1 FY2022Mar 31, 2022-$44.76M–
Q4 FY2021Dec 31, 2021-$41.26M–
Q3 FY2021Sep 30, 2021-$29.07M–
Q2 FY2021Jun 30, 2021-$28.36M–
Q1 FY2021Mar 31, 2021-$49.77M–
Q4 FY2020Dec 31, 2020-$28.20M–
Q3 FY2020Sep 30, 2020-$20.73M–
Q2 FY2020Jun 30, 2020-$9.34M–
Q1 FY2020Mar 31, 2020-$11.42M–
Q4 FY2019Dec 31, 2019-$23.38M–
Q3 FY2019Sep 30, 2019-$7.11M–
Q2 FY2019Jun 30, 2019-$5.21M–
Q1 FY2019Mar 31, 2019-$807.00K–
Q4 FY2018Dec 31, 2018-$302.00K–

More Phathom Pharmaceuticals figures

See a number that looks wrong?